Top headlines in major S. Korean newspapers
SEOUL, Oct. 30 (Yonhap) -- The following are the top headlines in major South Korean newspapers on Oct. 30.
Korean-language dailies
-- Half of public sees Moon administration's property policy responsible for soaring prices: survey (Kyunghyang Shinmun)
-- Some 60 prosecutors revolt against justice minister (Kookmin Daily)
-- Ruling party moves to nominate candidates for Seoul, Busan by-elections (Donga llbo)
-- Democratic Party to produce candidates for Seoul, Busan mayoral races (Seoul Shinmun)
-- Bank loans for 20-somethings surge 47 pct amid real estate, stock investment boom (Segye Times)
-- Prosecutors engage in group resistance against justice minister (Chosun Ilbo)
-- Lime Asset siphoned off 125 bln won of investment overseas (JoongAng Ilbo)
-- Ruling party moves to revise party constitution to run in Seoul, Busan by-elections (Hankyoreh)
-- Supreme Court confirms ex-President Lee's 17-year jail term (Hankook Ilbo)
-- Black trading grows in housing rent market (Maeil Business Newspaper)
-- Samsung Electronics posts record earnings, to invest 35 tln won by end of 2020 (Korea Economic Daily)
English-language dailies
-- Ex-President Lee loses appeal, gets 17 years in jail (Korea JoongAng Daily)
-- Biden will be more rigorous on North Korea, experts say (Korea Herald)
-- Virus spread continues as distancing rules eased (Korea Times)
(END)
-
BTS to appear on Korean TV shows this month
-
BLACKPINK's Rose to drop solo album next week
-
(LEAD) 2 patients die after AstraZeneca vaccine shots; study under way over potential connection
-
Three more die after receiving AstraZeneca vaccine
-
J-Hope releases new song 'Blue Side' on 'Hope World' anniversary
-
Couple indicted on murder charge over fatal abuse of 10-year-old niece
-
(LEAD) S. Korea, U.S. reach defense cost-sharing agreement
-
85,000 foreign workers in Gyeonggi ordered to take COVID-19 test before March 22
-
S. Korea tentatively concludes no link between COVID-19 vaccination and deaths
-
2 nurses test positive for COVID-19 after Pfizer vaccine shots